Entomopathogenic Potential of a Species of Serratia marcescens Originating from the Gut of Melon Fly: Isolation, Characterization and Effect of Oral Administration
Journal of Experimental Zoology Part A: Ecological and Integrative Physiology · 2026-06 · 345 (5) · 508-522
DOI: 10.1002/jez.70085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Zoology Part A: Ecological and Integrative Physiology, online erschienen am 30.03.2026. Verfasst von Yi Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Yangtze University, Jingzhou, Hubei, China. Hauptthemen laut MEDLINE: Serratia marcescens, Tephritidae, Pest Control, Biological. Die Arbeit nennt 70 Literaturangaben.
Abstract (Originalsprache)
The melon fly, Bactrocera cucurbitae (Coquillett), represents a devastating agricultural pest species. Conventional chemical control strategies are increasingly compromised by the development of insecticide resistance. Given the pivotal role of the gut microbiota in insect physiology and host fitness, it is necessary to isolate gut‐derived bacterial strains from adult melon flies and assess their insecticidal efficacy against adult flies. Isolation of culturable gut microbiota from adult melon flies that died of natural causes yielded 122 bacterial strains. Among the 10 virulent bacterial isolates, Serratia marcescens strain SMLY‐1 was identified as a highly pathogenic strain against adult melon flies. In addition, oral administration of SMLY‐1 significantly reduced survival rates of adult melon flies in a dose‐dependent manner. Histopathological analysis suggested that SMLY‐1 administration resulted in progressive midgut damage, which was manifested by epithelial cell desquamation and vacuolization. Moreover, the gut microbiota homeostasis was disrupted, and microbial richness was reduced. Notably, the genus‐level Wilcoxon signed‐rank test showed a significant increase in Serratia spp. abundance in the SMLY‐1 treatment group compared to the control group, indicating abnormal proliferation of Serratia spp. in intestines. Enzymatic assays showed that key digestive enzymes (AMS, LPS, trypsin) and detoxification enzymes (CarE, GST) activities were significantly reduced as well as antioxidant enzymes exhibited significant alterations. qRT‐PCR results suggested that immune‐related genes in adult melon flies including Attacin , JNK , and PPO were sustained upregulated whereas Cecropin , PGRP , IMD and GST were significantly downregulated. These findings establish SMLY‐1 as a promising candidate for the biocontrol of melon flies in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Life Sciences, Yangtze University, Jingzhou, Hubei, China.
- Guangxi Key Laboratory for Biology of Crop Diseases and Insect Pests, Institute of Plant Protection, Guangxi Academy of Agricultural Sciences, Nanning, Guangxi, China.
Zitieren
APA
Li, Y., Chen, L., Lu, C., Yu, X., Li, W., & Gao, X. (2026). Entomopathogenic Potential of a Species of Serratia marcescens Originating from the Gut of Melon Fly: Isolation, Characterization and Effect of Oral Administration. Journal of Experimental Zoology Part A: Ecological and Integrative Physiology, 345(5), 508-522. https://doi.org/10.1002/jez.70085
Vancouver
Li Y, Chen L, Lu C, Yu X, Li W, Gao X. Entomopathogenic Potential of a Species of Serratia marcescens Originating from the Gut of Melon Fly: Isolation, Characterization and Effect of Oral Administration. Journal of Experimental Zoology Part A: Ecological and Integrative Physiology. 2026;345(5):508-522. doi:10.1002/jez.70085
BibTeX
@article{Li2026,
author = {Li, Yi and Chen, Lifei and Lu, Chongyang and Yu, Xun and Li, Wei and Gao, Xuyuan},
title = {Entomopathogenic Potential of a Species of Serratia marcescens Originating from the Gut of Melon Fly: Isolation, Characterization and Effect of Oral Administration},
journal = {Journal of Experimental Zoology Part A: Ecological and Integrative Physiology},
year = {2026},
volume = {345},
number = {5},
pages = {508--522},
doi = {10.1002/jez.70085}
}
EUVIMED